Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MEDI.OL NO Equity

Medistim ASAHealth Care · FY ends Dec 31
NOK 236.00
-3.00 (-1.26%)
NOK · as of 2026-08-17 · marketstack
3 registered studies · 2 active

Studies where MEDI.OL is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.

3 observational

government filings 180d: none disclosed

StudyPhaseStatusInterventionsConditionsEnrollmentPrimary completionReadout inUpdated
Collect Flow and Ultrasound Images of Coronary Bypass GraftsNCT06360224observationalWide and high-quality dataset uploaded to CaseCloud from CABG-procedures.Not yet recruitingDevice: MiraQ systems with Transit Time Flow Measurement (TTFM) and High Frequency Ultrasound (HFUS) probesCardiac Bypass Surgery (CABG)1002029-05-15in 1,000 d2024-04-11
Peripheral Bypass Trial for Completion ControlNCT06264843observationalPrimary graft patency rateRecruitingDevice: MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probesChronic Limb-Threatening Ischemia450Dec 2027≤ 499 d2025-10-14
Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass SurgeryNCT02385344observationalChange in planned surgical procedureCompletedDevice: Medistim deviceCoronary Artery Bypass1,046Dec 2017actual2018-09-07

Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.

Source: ClinicalTrials.gov, retrieved 2026-08-19